J&J’s Path Forward – An Interview With Alex Gorsky
This article was originally published in The Tan Sheet
Executive Summary
In a conversation shortly before taking the helm at Johnson & Johnson, CEO Gorsky discusses deal strategies, emerging markets, his experience overseeing both the device and pharma businesses and the value of J&J’s consumer health product portfolio.
You may also be interested in...
J&J CEO Choice Likely Will Not Raise Consumer Business Profile
Alex Gorsky will replace William Weldon as Johnson & Johnson CEO in April. Like his predecessor, who has led during a time of extensive OTC recalls, Gorsky’s experience with J&J comprises management of Rx pharmaceutical and medical device businesses, with no consumer background.
The New Math Of Ortho Innovation – An Interview With Zimmer CEO David Dvorak
After emerging from the DOJ settlements, the leading pure-play orthopedics company is emphasizing – and redefining – innovation to drive growth. Zimmer CEO David Dvorak talks to IN VIVO about his company’s commitment to innovation, and how the very notion of innovation is changing.
Medtech Innovation From An Industrial Perspective: An Interview With GE Healthcare’s John Dineen
Because the GE brand is so ubiquitous, visible on everything from household appliances to airplane engines, it’s easy to assume a familiarity with GE and, in particular, with what its health care business is all about. But this interview with John Dineen, President and CEO of GE Healthcare and GE Medical Systems Information Technologies Inc. makes clear that GE’s world view is anything but familiar and stands in striking contrast to that of most other medical technology companies.